During the past decade, Centrum Medyczne Plejady conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 23 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 21 clinical trials were completed. i.e. 56.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Plejady" #1 sponsor was "Pfizer" with 10 trials, followed by "Celgene" with 8 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Takeda" with 6 trials sponsored and "Galapagos NV" with 6 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Plejady" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Plejady" are "Ulcerative Colitis" (9 trials), "Systemic Lupus Erythematosus" (8 trials), "Crohn Disease" (6 trials), "Rheumatoid Arthritis" (4 trials) and "Dermatomyositis" (3 trials). Many other conditions were trialed in "Centrum Medyczne Plejady" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Plejady" are "Drug" (66 trials), "Other" (13 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Guselkumab" (4 trials), "Soticlestat" (4 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Plejady" are 72 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Medyczne Plejady". undefined are not yet recruiting, 17 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Centrum Medyczne Plejady, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Plejady, 2 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".